Jenny I-Chen Li

Deputy Section Manager
Grape King Bio

​

Dr. Jenny I-Chen Li is a leader in biotech innovation who has built over 20 advanced testing platforms using the latest science. Her research has changed how we develop new ingredients and understand how they work. She has published 35 scientific papers (25 as first author), with a top impact factor of 12.06 and 592 citations. Her innovations have earned 23 international patents.
As a fermentation expert, Dr. Li has transformed mushroom-based health ingredients. Her work with Phellinus linteus/Sanghuangporus sanghuang mycelium has shown great potential for radiation protection, blood sugar control, muscle growth and fat burning. Through smart fermentation methods, she increased hispidin content from 1 mg/g to 200 mg/g—a 20,000% improvement. Her research has led to successful products like "Propartner's Ning Kang Fu Capsules," "Propartner's Tang Li Jia Capsules," and "Kang Er Dong Pro & Prebiotics." Her team produces about four tons of high-quality materials yearly, always improving through scientific testing.
At Grape King Bio, Dr. Li shows strong commitment to careful research and development of effective health ingredients. She believes true innovation comes from both new discoveries and teamwork that creates products with real health benefits. This recognition drives her to keep contributing to Taiwan's growing biotech industry.​

 

Speech title & Synopsis

Company Profile

Established in 1969, Grape King Bio has become one of Taiwan’s leading biotechnology companies, recognized for its specialization in medicinal mushrooms and probiotics. The company maintains a raw ingredient production capacity of 506 tons per day and offers a wide range of dosage form manufacturing. Its production facilities are certified to international standards, including ISO 22000, HACCP, and GMP, reflecting a strong commitment to product quality and safety.
The company also include state-of-the-art research facilities employ over 50 scientists dedicated to natural product discovery and development. This commitment to scientific excellence has earned Grape King Bio multiple National Industrial Innovation Awards, 209 patents, 277 international awards, and 148 publications in scientific journals.
At the core of Grape King Bio’s research philosophy is the belief that nature holds the key to addressing many health challenges. Through proprietary fermentation technology, the company cultivates medicinal mushroom mycelia with consistent potency and purity, enabling the extraction and standardization of bioactive compounds for optimal efficacy.
Grape King Bio’s current innovative product portfolio includes:
• Cordyceps cicadae mycelia CordyilightTM: Clinically proven for glaucoma and dry eye syndrome
• Hericium erinaceus mycelia HeripeneTM: Clinically validated for mild Alzheimer's disease and hearing loss
• Antrodia cinnamomea mycelia GK ACTM: Clinically proven for blood pressure, anti-HBV, NASH, and anti-tumor effects
• Sanghuangporus sanghuang mycelia SangMAXTM and MyoSSTM: For metabolic health and muscle development
• Advanced Probiotics: Patented strains supporting anti-allergy, anti-aging, osteoarthritis, anxiety reduction, weight management, and sports performance
Each product undergoes rigorous quality control and standardization to ensure consistent bioactive compound content.
Through strategic collaborations with leading academic institutions and healthcare organizations worldwide, Grape King Bio continuously advances its understanding of natural bioactive compounds and their applications for human health. The company's vision is to harness nature's wisdom through science, creating innovative health solutions that improve quality of life.